A Randomized Double Dummy Double Blind Dose Determining Place-bo Controlled Study to Evaluate Efficacy of Investigational Product E-RH-06 at 2 Dose Levels for the Metabolic Management of Chronic or Recurrent, Non-infective Nasal Congestion With-or-without Rhinorrhea.

NCT01546662 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Rhinitis

Interventions

DIETARY_SUPPLEMENT: E-RH-06
DIETARY_SUPPLEMENT: Placebo

Sponsor

Enovate Biolife Pvt Ltd